• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Portfolio

/ October 5, 2021

Deltech LLC

Deltech is a leading producer of specialty aromatic monomers, polystyrene and resins for use in coatings, composites, construction materials and other applications.  The Company is the largest producer globally of the specialty aromatic monomer products vinyl toluene, para-methyl styrene, and para-tertiary butyl styrene from its site in Baton Rouge, LA.  Deltech also produces crystal polystyrene from its Troy, OH location as well as alkyd and unsaturated polyester resins from its Haverhill, U.K. site.

SK Capital acquired a controlling interest in Deltech in August 2021.

For more information, please visit https://www.deltechcorp.com/

 

Primary Sidebar

Latest News

  • Lacerta Group Announces Acquisition of Portage Plastics Assets

    January 9, 2023
  • SK Capital Announces Promotions

    January 3, 2023
  • SK Capital Partners and Edgewater Capital Partners Close Acquisition of Crystals Business from Saint-Gobain

    December 1, 2022

SK Capital Portfolio Companies

  • Luxium Solutions
  • VanDeMark Chemical, Inc
  • Valtris Specialty Chemicals
  • Florachem
  • Heubach
  • Seqens
  • Deltech LLC
  • Canlak
  • IPACKCHEM
  • Woodstock Sterile Solutions
  • Lacerta Group
  • Venator
  • Tilley Distribution
  • NuCera Solutions
  • Techmer PM
  • GEON
  • SI Group
  • Perimeter Solutions
  • Wavelength
  • Foremark
  • Tri-Tex
  • Niacet
  • Noramco
  • Extractas Bioscience
  • Purisys
  • Archroma
  • Addivant
  • TPC Group
  • Ascend
  • IBA Molecular
  • Calabrian Corporation
  • Halo Pharmaceutical
  • AEB Group

To request for a copy of our ESG report, please click here.

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login